Chetana Revankar
Chetana Revankar
Verified email at lifetech.com
Title
Cited by
Cited by
Year
A transmembrane intracellular estrogen receptor mediates rapid cell signaling
CM Revankar, DF Cimino, LA Sklar, JB Arterburn, ER Prossnitz
Science 307 (5715), 1625-1630, 2005
22352005
Virtual and biomolecular screening converge on a selective agonist for GPR30
CG Bologa, CM Revankar, SM Young, BS Edwards, JB Arterburn, ...
Nature chemical biology 2 (4), 207-212, 2006
7362006
GPR30: a novel indicator of poor survival for endometrial carcinoma
HO Smith, KK Leslie, M Singh, CR Qualls, CM Revankar, NE Joste, ...
American journal of obstetrics and gynecology 196 (4), 386. e1-386. e11, 2007
2302007
Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30
CM Revankar, HD Mitchell, AS Field, R Burai, C Corona, C Ramesh, ...
ACS Chemical Biology 2 (8), 536-544, 2007
1702007
Arrestins block G protein-coupled receptor-mediated apoptosis
CM Revankar, CM Vines, DF Cimino, ER Prossnitz
Journal of Biological Chemistry 279 (23), 24578-24584, 2004
1322004
N-formyl peptide receptors internalize but do not recycle in the absence of arrestins
CM Vines, CM Revankar, DC Maestas, LL LaRusch, DF Cimino, ...
Journal of Biological Chemistry 278 (43), 41581-41584, 2003
1312003
Parallel functional activity profiling reveals valvulopathogens are potent 5-hydroxytryptamine2B receptor agonists: implications for drug safety assessment
XP Huang, V Setola, PN Yadav, JA Allen, SC Rogan, BJ Hanson, ...
Molecular pharmacology 76 (4), 710-722, 2009
1042009
Calmodulin modulates Akt activity in human breast cancer cell lines
CM Coticchia, CM Revankar, TB Deb, RB Dickson, MD Johnson
Breast cancer research and treatment 115 (3), 545, 2009
662009
Estrogen Receptors and Cell Signaling/Response
RJ Pietras, ER Levin, CM Szego, ER Prossnitz
Science 310 (5745), 51, 2005
552005
Linkage Effects on Binding Affinity and Activation of GPR30 and Estrogen Receptors ERα/β with Tridentate Pyridin-2-yl Hydrazine Tricarbonyl−Re/99mTc(I) Chelates
C Ramesh, BJ Bryant, T Nayak, CM Revankar, T Anderson, KE Carlson, ...
Journal of the American Chemical Society 128 (45), 14476-14477, 2006
412006
Utilization of the TangoTM β-Arrestin Recruitment Technology for Cell-Based EDG Receptor Assay Development and Interrogation
JA Wetter, C Revankar, BJ Hanson
Journal of biomolecular screening 14 (9), 1134-1141, 2009
382009
A homogeneous fluorescent live-cell assay for measuring 7-transmembrane receptor activity and agonist functional selectivity through beta-arrestin recruitment
BJ Hanson, J Wetter, MR Bercher, L Kopp, M Fuerstenau-Sharp, ...
Journal of biomolecular screening 14 (7), 798-810, 2009
372009
Adaptor Protein‐2 Interaction with Arrestin Regulates GPCR Recycling and Apoptosis
BM Wagener, NA Marjon, CM Revankar, ER Prossnitz
Traffic 10 (9), 1286-1300, 2009
332009
Compounds for binding to ERα/β and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof
ER Prossnitz, SE Tkatchenko, CM Revankar, LA Sklar, JB Arterburn, ...
US Patent 7,875,721, 2011
72011
A selective ligand for estrogen receptor proteins discriminates rapid and genomic signaling
CM Revankar, CG Bologa, RA Pepermans, G Sharma, WK Petrie, ...
Cell Chemical Biology 26 (12), 1692-1702. e5, 2019
42019
Compounds for binding to ER alpha/beta and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof
ER Prossnitz, SE Tkatchenko, CM Revankar, LA Sklar, JB Arterburn, ...
US Patent 8,487,100, 2013
42013
A Novel Screening Approach for the Dissection of Cellular Regulatory Networks of NF-κB Using Arrayed CRISPR gRNA Libraries
P O’Shea, J Wildenhain, M Leveridge, C Revankar, JP Yang, J Bradley, ...
SLAS DISCOVERY: Advancing the Science of Drug Discovery, 2472555220926160, 2020
12020
Abstract LB-112: Unraveling biology and identifying targets with functional genomics approaches using lentiarray crispr libraries
CM Revankar, J Braun, JP Yang, J Wetter, T Gokirmak, N Ravinder, ...
Cancer Research 79 (13 Supplement), LB-112-LB-112, 2019
2019
Identifying novel and druggable targets in a triple negative breast cancer cell line using the Invitrogen LentiArray Human Kinase CRISPR Library
T Gokirmak, J Sharp, C Revankar, DR Piper
CANCER RESEARCH 78 (13), 2018
2018
Generation of clonal CRISPR/Cas9-edited human iPSC derived cellular models and its applications in physiologically relevant assays
CM Revankar, E Willems, R Lacambacal, T Gokirmak, J Dizon, J Webb, ...
CANCER RESEARCH 78 (13), 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20